For years I thought my physical pain and my mental health were two separate problems. I had depression that wouldn't respond fully to medication. Anxiety that would spike randomly. A sense of doom that felt disproportionate to whatever was happening around me. My therapist was great. My antidepressant helped. But something was still off, like I was fighting a war on two fronts and winning on neither.
It wasn't until I understood the mechanics of my endometriosis that I realized these weren't entirely separate problems. They were connected through biological pathways. My brain wasn't the problem. It was responding to years of chronic pain and inflammation.
Does endometriosis cause depression and anxiety?
Yes — endometriosis significantly increases the risk of both depression and anxiety. Women with endometriosis have roughly 1.5 times the risk of depression, 1.4 times the risk of anxiety, and twice the risk of self-directed violence compared to women without the disease. The relationship is bidirectional and biological: chronic inflammation, hormonal swings, persistent pain, and years of medical dismissal each contribute to measurable changes in brain chemistry and stress regulation.
This isn't "feeling sad about being sick." Large cohort studies, sibling-controlled studies, and meta-analyses converge on the same finding: endometriosis itself raises mental health risk through specific biological pathways, not just through the psychological burden of living with a chronic illness. Studies consistently show that a substantial majority of people with endometriosis report depressive symptoms at some point during their disease course, and rates of anxiety and trauma-related symptoms are similarly elevated. A genome-wide association analysis from Yale identified shared genetic architecture between endometriosis, depression, and anxiety, suggesting some of the link runs at the level of biology rather than circumstance.
If you've been told your depression is "just" because you have a hard disease — that misses the science. Inflammatory cytokines from endometriotic lesions can cross the blood-brain barrier and directly alter neurotransmitter function. Pain rewires neural circuits. Repeated medical invalidation creates measurable nervous system changes. Understanding why this is happening is the first step in treating both sides of the problem effectively, instead of treating only the part you can see.
How common are depression and anxiety with endometriosis?
A large retrospective cohort study of over 72,000 women with endometriosis found significantly elevated rates of depression (HR 1.48), anxiety (HR 1.38), and self-directed violence (HR 2.03) compared to matched controls. A Swedish sibling study confirmed the association isn't entirely explained by shared family factors.
The association between endometriosis and mental health conditions is well-documented. The adjusted hazard ratio was 1.48 for depression, 1.38 for anxiety, and 2.03 for self-directed violence compared to matched controls.
A nationwide Swedish cohort study found that women with endometriosis had increased risk of depressive disorders (HR 1.56), anxiety and stress-related disorders, and other psychiatric conditions — even when compared to their own sisters without endometriosis, suggesting the association isn't entirely explained by shared family factors.
A meta-analysis of 24 studies (nearly 100,000 women) confirmed higher levels of depression among women with endometriosis compared to controls. Importantly, the association was strongest when comparing endometriosis patients to healthy controls, and pain appeared to be a key mediating factor — women with endometriosis and pelvic pain had significantly higher depression levels than those without pain.
This isn't just about being "depressed about having endometriosis." There appear to be biological mechanisms connecting the two conditions.
Why does endometriosis cause depression? The brain-body connection
Endometriosis affects mental health through five overlapping biological pathways: inflammation that crosses into the brain, the kynurenine pathway that diverts serotonin precursors, estrogen fluctuations that destabilize mood, chronic pelvic pain that rewires neural circuits, and the medical trauma of years of dismissal. These mechanisms run in parallel, which is why treatment that addresses only one piece often plateaus.
The depression and anxiety you experience aren't separate from your endometriosis — they're driven by it. Each of the next five sections explains one of these drivers in detail and what the evidence actually says about it. None of these mechanisms are speculative. Each is supported by mechanism research, clinical studies, or both. The point isn't to hand you another list of things to feel bad about. It's to map the actual terrain so that the treatment plan can match the problem.
How does inflammation affect the brain in endometriosis?
Peripheral cytokines from endometrial lesions can cross the blood-brain barrier, signal through the vagus nerve, and activate brain immune cells called microglia — altering neurotransmitter systems including serotonin, dopamine, and glutamate. Neuroinflammation affects up to 27% of patients with major depressive disorder and is associated with treatment-resistant trajectories.
One of the most important mechanisms connecting endometriosis to mental health involves inflammation. Endometrial lesions produce inflammatory cytokines, including IL-1β, IL-6, and TNF-α. These are chemical messengers that signal danger.
Research shows that peripheral cytokines can affect the brain through several pathways: they can cross the blood-brain barrier, signal through the vagus nerve, and activate immune cells in the brain called microglia. Once inflammation reaches the central nervous system, it can alter neurotransmitter systems including serotonin, dopamine, and glutamate.
This isn't unique to endometriosis. The Lancet's review on depression notes that peripheral cytokines can act directly on neurons and supporting cells after traversing the blood-brain barrier. This helps explain why individuals with autoimmune diseases and chronic inflammatory conditions are more likely to have depression.
Neuroinflammation affects up to 27% of patients with major depressive disorder and is associated with a more severe, chronic, and treatment-resistant trajectory. Higher plasma levels of inflammatory cytokines — most consistently IL-1β, IL-6, and TNF-α — are correlated with greater depressive symptomatology.
What is the kynurenine pathway in endometriosis depression?
When inflammatory cytokines are elevated, they activate an enzyme that diverts tryptophan — the amino acid precursor to serotonin — away from serotonin production and toward neurotoxic compounds like quinolinic acid. This mechanism is well-established in inflammation-related depression, though its specific role in endometriosis hasn't been extensively studied.
One specific mechanism linking inflammation to depression involves the kynurenine pathway. When inflammatory cytokines are elevated, they activate an enzyme called indoleamine-2,3-dioxygenase (IDO), which diverts tryptophan — the amino acid precursor to serotonin — down an alternative metabolic pathway.
Instead of being converted to serotonin, tryptophan gets converted to kynurenine and its downstream metabolites, including quinolinic acid. Quinolinic acid is neurotoxic and can contribute to excitotoxicity and neuroinflammation.
A systematic review found that interferon-alpha treatment (which activates the immune system) was associated with decreased tryptophan, increased kynurenine, and increased depression scores. This suggests that immune activation can directly affect mood through this pathway.
I want to be clear about what we know: while the kynurenine pathway is well-established in inflammation-related depression generally, the specific role of this pathway in endometriosis-related depression hasn't been extensively studied. The mechanism is plausible but not proven specifically for endometriosis.
Does estrogen affect mood in endometriosis?
Estrogen fluctuations — rather than simply high or low levels — may be most relevant to mood. A meta-analysis found that exogenous estrogen improved depressive mood in women, with the effect associated with age rather than dose. The primary driver of kynurenine pathway activation is inflammatory cytokines, not estrogen itself.
Research shows that estrogen fluctuations — rather than simply high or low levels — may be most relevant to mood. A meta-analysis of randomized controlled trials found that exogenous estrogen improved depressive mood in women, particularly during perimenopause. The effect was associated with age rather than dose, suggesting that a stable level of estrogen is more beneficial than a high serum level.
Estrogen does modulate neurotransmitter systems, stress axis activation, neuroplasticity, and immune function. A JAMA Psychiatry study found that women with a history of perimenopausal depression were more likely to develop depressive symptoms when estradiol was withdrawn, suggesting some women are more sensitive to estrogen changes than others.
However, the claim that endometriosis-related "estrogen dominance" directly shunts tryptophan away from serotonin production is an oversimplification. While estrogen can influence the kynurenine pathway, the primary driver of kynurenine pathway activation is inflammatory cytokines, not estrogen itself.
Does chronic pelvic pain cause depression?
The meta-analysis on endometriosis and depression found that the association is largely determined by chronic pain. Chronic pain and depression share overlapping neural circuits and neurotransmitter systems, and chronic pain causes measurable changes in brain structure and function. Effective pain management is an important component of addressing mental health.
The meta-analysis found that the association between endometriosis and depressive symptoms is largely determined by chronic pain. Women with endometriosis and pelvic pain had significantly higher depression levels than those without pain.
Chronic pain and depression share overlapping neural circuits and neurotransmitter systems. Living with persistent pain is psychologically exhausting. It disrupts sleep, limits activities, strains relationships, and creates uncertainty about the future.
This doesn't mean the depression is "just psychological" — chronic pain causes measurable changes in brain structure and function. But it does mean that effective pain management is an important component of addressing mental health in endometriosis.
Is medical trauma part of endometriosis mental health?
Many people with endometriosis spent years being dismissed by providers, with average diagnostic delays of 5–12 years. Repeated invalidation from authority figures can affect nervous system regulation, creating hypervigilance and healthcare-specific anxiety that compounds the biological mechanisms already at play.
There's also a psychological and social dimension that compounds this. Many people with endometriosis spent years — sometimes decades — being dismissed. Your pain was "not that bad." Your symptoms were "in your head." You were told to "just have a baby" or "exercise more."
Research confirms this experience. The average diagnostic delay is 5–12 years, and most women see multiple clinicians before receiving a diagnosis. Studies have documented that dismissal and disbelief by medical professionals is a common experience.
Repeated invalidation from authority figures can affect how your nervous system responds. You may become hypervigilant about symptoms. You may develop anxiety about healthcare itself. This psychological burden adds to the biological mechanisms already at play.
Does endometriosis cause brain fog?
Yes — a large survey study found cognitive impairments in approximately 80% of participants with endometriosis, including memory lapses, word-finding difficulty, and trouble concentrating. The same inflammatory cytokines that drive depression also activate brain immune cells called microglia, affect the hippocampus and prefrontal cortex, and impair attention and short-term memory. A 2025 commentary in The Lancet Obstetrics, Gynaecology, & Women's Health described brain fog as the overlooked symptom of endometriosis and recommended that it be assessed routinely in clinical care, not dismissed as fatigue or stress.
The mechanisms overlap directly with depression. Inflammatory cytokines like IL-6 and TNF-α reach the brain through the blood-brain barrier and the vagus nerve, where they activate microglia. Chronic microglial activation produces neuroinflammation that specifically disrupts the hippocampus (memory formation) and the prefrontal cortex (executive function and attention). This is why brain fog tends to track with disease activity — flaring with your cycle, worsening during severe pain weeks, and improving when inflammation is better controlled.
Iron deficiency from heavy menstrual bleeding compounds this. Even when ferritin sits in the "low-normal" range, brain iron stores can be depleted enough to impair cognition. Pain itself also drains cognitive resources — the brain devotes a substantial fraction of its processing capacity to monitoring chronic pain signals, leaving less available for everything else. Sleep disrupted by pain and anxiety further limits the cognitive consolidation that normally happens overnight.
If you've been told you have ADHD or that you're "just stressed," and your cognitive symptoms track your menstrual cycle or worsen during flares, the change is more likely a feature of your endometriosis than a separate diagnosis. Treating the underlying inflammation, correcting iron deficiency with adequate ferritin (not just hemoglobin) targets, and addressing pain-driven sleep loss often improves cognition meaningfully — though gradually rather than overnight.
Why doesn't my antidepressant fully work for endometriosis?
SSRIs and SNRIs work by increasing serotonin and norepinephrine availability in the synapse, but they don't reduce the inflammation driving the problem in the first place. If your depression is fueled by ongoing cytokine elevation and kynurenine pathway activation from your endometriosis, blocking serotonin reuptake addresses the downstream symptom while the upstream source keeps running. That's the mismatch most patients on multiple antidepressant trials are running into.
Research on inflammatory subtypes of depression supports this clinically. Patients with elevated inflammatory markers — particularly IL-6, TNF-α, and CRP — tend to respond less robustly to standard antidepressants and are more likely to fall into the treatment-resistant category. Up to 27% of patients with major depressive disorder show measurable neuroinflammation, and these patients have a more severe and chronic course. If your endometriosis is uncontrolled, you have a higher likelihood of being in that subgroup.
This doesn't mean antidepressants don't help. They often do, and they're often necessary. It means that for many people with endometriosis, antidepressants are one piece of a multimodal approach rather than a complete solution. Addressing the inflammatory source (through hormonal suppression, surgical excision, or targeted anti-inflammatory strategies), treating the pain that drives central sensitization, and working with a therapist trained in chronic illness all contribute to outcomes that medication alone cannot achieve.
If you've gone through three antidepressants with partial response and your endometriosis is still uncontrolled, the answer may not be a fourth medication trial. The answer may be addressing the disease that's keeping the inflammation going.
Does treating endometriosis improve depression?
A systematic review found that medical and surgical interventions significantly improved quality of life. One study of women with stage 4 endometriosis found significant decreases in depression and increases in sleep quality after surgery. However, postoperative hormonal therapy alone did not significantly reduce psychiatric disorder risk, suggesting a multimodal approach is needed.
The evidence suggests yes. A systematic review found that medical and surgical interventions significantly decreased experienced burdens and improved quality of life in women with endometriosis. Studies specifically examining depression and anxiety have found improvements after surgery.
One study of women with stage 4 endometriosis found a significant decrease in depression complaints and a significant increase in sleep quality after surgery. A meta-analysis found significant improvement in emotional well-being after surgery for all types of endometriosis.
However, a recent study found that postoperative hormonal therapy did not significantly reduce the risk of psychiatric disorders compared to surgery alone. This suggests that while treating the disease helps, the relationship between endometriosis and mental health is complex and may require attention to both physical and psychological factors.
Cognitive behavioral therapy (CBT) has also been shown to help. One study found that CBT combined with usual care significantly reduced anxiety in women after endometriosis surgery compared to usual care alone.
What actually helps endometriosis depression and anxiety?
Address both sides simultaneously: continue therapy and medication while treating the endometriosis itself. A 2024 review emphasized that a holistic approach combining prompt diagnosis, targeted medical interventions, and psychological support produces the best outcomes.
You're not the problem. Your brain is responding to chronic pain, inflammation, and often years of medical dismissal. That's not weakness.
Address both sides. Continue with therapy and medication if they're helping — that's not wasted effort. But also treat the endometriosis itself, through whatever combination of approaches makes sense for you. Mental health and physical health are connected.
Be patient with the timeline. If inflammation has been affecting your brain for years, improvement may be gradual rather than dramatic. That's still progress.
A 2024 review in Fertility and Sterility emphasized that healthcare providers who treat women with endometriosis should be aware of these associations, recommending "a holistic approach by gynecologists as well as mental health professionals" that emphasizes prompt diagnosis, targeted medical interventions, and psychological support.
You're not losing your mind. Your mind is responding to your body's crisis. Once we address that crisis — through treating the disease, managing pain, and supporting your mental health — things can get better.
What to say to your doctor about endometriosis mental health
The right framing helps. Doctors often respond differently when you connect mental health symptoms to your physical disease and to specific research, rather than presenting them as separate or psychological. Below are scripts for the most common situations, with the citation hooks to make the conversation move.
If your antidepressant isn't fully working:
"My depression hasn't fully responded to [medication name]. I have endometriosis with active inflammation, and research suggests that inflammatory subtypes of depression often respond less to SSRIs alone. Can we discuss whether better disease control — through hormonal suppression, dienogest, or excision surgery — might improve my response, and whether anti-inflammatory strategies could be added alongside the medication?"
If you're being told your symptoms are "just anxiety":
"I appreciate that anxiety is part of what I'm experiencing, but I want to flag that endometriosis is associated with a hazard ratio of 1.38 for anxiety disorders in large cohort studies. The biology — inflammatory cytokines reaching the brain, the kynurenine pathway, hormonal fluctuations — produces measurable changes that aren't only psychological. Can we treat my anxiety and my endometriosis as connected rather than separate problems?"
If you're experiencing healthcare-related anxiety after years of dismissal:
"I want to be upfront: I have a history of being dismissed by providers, which has made medical appointments anxiety-provoking for me. This is documented in endometriosis research and isn't unusual given an average diagnostic delay of five to twelve years. Can we work together so I feel safe asking questions, and so I'm not dismissed again? I do my best work as a patient when I feel I'm being believed."
If you're worried about thoughts of self-harm:
"I want to tell you that I've been having thoughts about [self-harm / not wanting to be here]. Endometriosis is associated with a hazard ratio of 2.03 for self-directed violence in large cohort studies — this isn't unusual, but it isn't safe to ignore either. I need help with both my mental health and my endometriosis." If you are in crisis, call or text 988 in the United States, or your country's equivalent crisis line, to reach a trained counselor immediately.
Frequently Asked Questions
Is my depression caused by endometriosis or is it separate?
It may be both. Large cohort studies show endometriosis is associated with significantly elevated rates of depression and anxiety through biological mechanisms — inflammatory cytokines affecting brain chemistry and the kynurenine pathway diverting serotonin precursors. Pain also mediates the relationship. These biological pathways exist alongside any psychological factors.
Will treating my endometriosis improve my mental health?
Evidence suggests yes — studies show significant improvement in depression scores and quality of life after surgery. However, postoperative hormonal therapy alone didn't significantly reduce psychiatric disorder risk, suggesting a multimodal approach (treating the disease + psychological support) produces the best outcomes.
Why doesn't my antidepressant fully work?
If inflammation is driving some of your depressive symptoms, SSRIs alone may not fully address the problem because the underlying inflammatory process continues to affect neurotransmitter systems. Addressing the inflammatory source (the endometriosis itself) alongside medication may improve response.
Is it normal to have anxiety about medical appointments after years of being dismissed?
Yes. Repeated invalidation by healthcare providers is a documented experience in endometriosis, with average diagnostic delays of 5–12 years. This can create healthcare-specific anxiety and hypervigilance that compounds the biological mechanisms. Acknowledging this as real — not weakness — is an important first step.
References
- Estes SJ, Huisingh CE, Chiuve SE, Petruski-Ivleva N, Missmer SA. Depression, anxiety, and self-directed violence in women with endometriosis: a retrospective matched-cohort study. Am J Epidemiol. 2021;190(5):843–852. doi:10.1093/aje/kwaa249
- Gao M, Koupil I, Sjöqvist H, et al. Psychiatric comorbidity among women with endometriosis: nationwide cohort study in Sweden. Am J Obstet Gynecol. 2020;223(3):415.e1–415.e16. doi:10.1016/j.ajog.2020.02.033
- Gambadauro P, Carli V, Hadlaczky G. Depressive symptoms among women with endometriosis: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019;220(3):230–241. doi:10.1016/j.ajog.2018.11.123
- Shih YH, Wang SJ, Fan CT, et al. Long-term risk of psychiatric disorders in women with endometriosis: a retrospective cohort study. Compr Psychiatry. 2025;136:152649. doi:10.1016/j.comppsych.2025.152649
- Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299–2312. doi:10.1016/S0140-6736(18)31948-2
- Miller AH. Advancing an inflammatory subtype of major depression. Am J Psychiatry. 2025;182(1):13–22. doi:10.1176/appi.ajp.20240655
- Hassamal S. Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Front Psychiatry. 2023;14:1130989. doi:10.3389/fpsyt.2023.1130989
- Hunt C, Macedo E Cordeiro T, Suchting R, et al. Effect of immune activation on the kynurenine pathway and depression symptoms — a systematic review and meta-analysis. Neurosci Biobehav Rev. 2020;118:514–523. doi:10.1016/j.neubiorev.2020.08.010
- Zhang J, Yin J, Song X, et al. The effect of exogenous estrogen on depressive mood in women: a systematic review and meta-analysis of randomized controlled trials. J Psychiatr Res. 2023;162:21–29. doi:10.1016/j.jpsychires.2023.04.011
- Schmidt PJ, Ben Dor R, Martinez PE, et al. Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry. 2015;72(7):714–726. doi:10.1001/jamapsychiatry.2015.0111
- Goksu M, Kadirogullari P, Seckin KD. Evaluation of depression and sleep disorders in the preoperative and postoperative period in stage 4 endometriosis patients. Eur J Obstet Gynecol Reprod Biol. 2021;263:86–89. doi:10.1016/j.ejogrb.2021.06.022
- Rempert AN, Rempert TH, Liu A, et al. A systematic review of the psychosocial impact of endometriosis before and after treatment. Reprod Sci. 2024;31(7):1828–1860. doi:10.1007/s43032-024-01515-w
- Arcoverde FVL, Andres MP, Borrelli GM, et al. Surgery for endometriosis improves major domains of quality of life: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2019;26(2):266–278. doi:10.1016/j.jmig.2018.09.774
- Zippl AL, Reiser E, Seeber B. Endometriosis and mental health disorders: identification and treatment as part of a multimodal approach. Fertil Steril. 2024;122(6):978–988. doi:10.1016/j.fertnstert.2024.08.351
- Wu S, Wang X, Liu H, Zheng W. Efficacy of cognitive behavioral therapy after the surgical treatment of women with endometriosis: a preliminary case-control study. Medicine. 2022;101(30):e29827. doi:10.1097/MD.0000000000029827
- Koller D, Pathak GA, Wendt FR, et al. Epidemiologic and genetic associations of endometriosis with depression, anxiety, and eating disorders. JAMA Netw Open. 2023;6(1):e2251214. doi:10.1001/jamanetworkopen.2022.51214
- Horn M, Sherman KA, Pehlivan MJ. Perceived cognitive functioning difficulties in individuals living with endometriosis. J Health Psychol. 2025;30(14):4314–4332. doi:10.1177/13591053251331826
- Mahony LE, Saunders PTK, Whitaker LHR, Horne AW. The overlooked symptom in endometriosis: brain fog. Lancet Obstet Gynaecol Womens Health. 2025 Nov 12 [Epub ahead of print]. https://www.research.ed.ac.uk/en/publications/the-overlooked-symptom-in-endometriosis-brain-fog/
